Title:
水性製剤及び注射器入り水性製剤、並びに、抗体タンパク脱凝集剤及び抗体タンパク脱凝集方法
Document Type and Number:
Japanese Patent JP7179717
Kind Code:
B2
Abstract:
An aqueous formulation comprises ustekinumab, at least one selected from histidine and salts thereof, and water, whereina content of the histidine and/or the salts thereof is 50 to 90 mM in terms of histidine.
Inventors:
Yoshiya Apansiri
Fujita Mitsunari
Fujita Mitsunari
Application Number:
JP2019510230A
Publication Date:
November 29, 2022
Filing Date:
March 30, 2018
Export Citation:
Assignee:
Meiji Seika Pharma Co., Ltd.
DONG A SOCIO HOLDINGS CO.,LTD.
DONG A SOCIO HOLDINGS CO.,LTD.
International Classes:
A61K39/395; A61K9/08; A61K47/18; A61K47/26; A61P17/06; A61P19/02; A61P37/02
Domestic Patent References:
| JP2005508981A | ||||
| JP2013544763A | ||||
| JP2016505572A | ||||
| JP2012510468A |
Foreign References:
| WO2012048134A2 |
Other References:
J. Physical Chemistry B, 2016, Vol.120, pp.7062-7075
Attorney, Agent or Firm:
Patent Attorney Corporation St. Crest International Patent Office